The part of care after the decision

Name the person who replies

Find out who reads a treatment message and how you receive their reply. Ask for the fallback contact as well. The name of a service’s online message system does not tell you who answers or how soon.

FDA’s September 2026 advice raises a concern about care after delivery: is a licensed doctor available for your medicine questions? A service without that contact is a warning sign.

Get the contact route in writing. Ask the service to distinguish ordinary messages from concerns that need a quicker response.

Agree what is being reviewed

Ask how your progress will be reviewed. Describe the daily tasks or goals that matter to you, what feels hard and what needs another explanation. Ask what notes to bring back.

For the next conversation, it may help to keep a brief note of what changed and which questions remain. Use plain descriptions. Let the person treating you supply the medical terms.

Leave space to change the plan

In SURMOUNT-4, people moved from tirzepatide to a dummy shot, called a placebo, and gained weight on average over the following year.

That trial does not establish that every person must remain on treatment forever.

Ask about the process for reviewing or stopping a plan. Bring up a change in budget or preference as well as a change in your goals. Ask who handles a gap in care or a move to a different service.

Revisit the whole bill

Ask whether a return visit is included, whether messaging has a separate charge and how a membership ends. Keep the written terms with your notes. A conversation about continuing care also belongs alongside a conversation about paying for it.

The September 2026 pricing review found care memberships and medicine commonly billed as separate costs.

Ask the service to spell out the ongoing amount, rather than carrying a first-month headline into the rest of the plan.